Literature DB >> 12270148

Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells.

Michiko Kawanishi1, Saeko Tada-Oikawa, Shosuke Kawanishi.   

Abstract

We have previously reported that TNF-related apoptosis inducing ligand (TRAIL) causes cleavage of Bid via activation of caspase-8 and the loss of mitochondrial membrane potential (DeltaPsim), resulting in apoptosis. Experiments with BJAB clones expressing Epstein-Barr virus (EBV) anti-apoptotic protein BHRF1 showed that BHRF1 drastically inhibited TRAIL-mediated apoptosis. Although Western blot analysis demonstrated that TRAIL-induced Bid cleavage was not inhibited by BHRF1, the decrease in DeltaPsim caused by TRAIL was effectively blocked by BHRF1. These findings suggest that in BJAB cells, BHRF1 acts downstream of Bid cleavage and upstream of mitochondrial damage, resulting in inhibition of TRAIL-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270148     DOI: 10.1016/s0006-291x(02)02261-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Dysfunction of mitochondria due to environmental carcinogens in nasopharyngeal carcinoma in the ethnic group of Northeast Indian population.

Authors:  Sankar Kumar Ghosh; Anil Seram Singh; Rosy Mondal; Wetetsho Kapfo; V Khamo; Y Indibor Singh
Journal:  Tumour Biol       Date:  2014-04-09

2.  The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases.

Authors:  Brett D Shepard; Andrew D Badley
Journal:  Antiinfect Agents Med Chem       Date:  2009-04-01

Review 3.  Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Zbigniew Wyżewski; Matylda Barbara Mielcarska; Karolina Paulina Gregorczyk-Zboroch; Anna Myszka
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

4.  Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints.

Authors:  Alessandro Laganà; Stefano Forte; Francesco Russo; Rosalba Giugno; Alfredo Pulvirenti; Alfredo Ferro
Journal:  J RNAi Gene Silencing       Date:  2010-05-24

5.  Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection.

Authors:  Svenja Wolff; Stephan Becker; Allison Groseth
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

6.  Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing.

Authors:  Jennifer N Rainho; Mauricio A Martins; Francesc Cunyat; Ian T Watkins; David I Watkins; Mario Stevenson
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

7.  Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.

Authors:  Mitra Esfandiarei; Honglin Luo; Bobby Yanagawa; Agripina Suarez; Darya Dabiri; Jianchang Zhang; Bruce M McManus
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus.

Authors:  Suzanne D Vernon; Toni Whistler; Barbara Cameron; Ian B Hickie; William C Reeves; Andrew Lloyd
Journal:  BMC Infect Dis       Date:  2006-01-31       Impact factor: 3.090

9.  An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

Authors:  Gemma L Kelly; Heather M Long; Julianna Stylianou; Wendy A Thomas; Alison Leese; Andrew I Bell; Georg W Bornkamm; Josef Mautner; Alan B Rickinson; Martin Rowe
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

Review 10.  Modulation of tumor necrosis factor by microbial pathogens.

Authors:  Masmudur M Rahman; Grant McFadden
Journal:  PLoS Pathog       Date:  2006-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.